WREG

Elgan Pharma and Chiesi Group Announce First Participating Infants Dosed in Phase 3 Study of ELGN-2112 for Treatment of Intestinal Malabsorption in Preterm Infants

NAZARETH, Israel and PARMA, Italy, June 5, 2025 /PRNewswire/ -- Elgan Pharma Ltd. and Chiesi Farmaceutici S.p.A today announced the dosing of the first participating infants in FIT-PIV, a Phase 3 ...
Seeking Alpha

Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes

JERUSALEM, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (ENTX) (NASDAQ: ENTX, “Entera”) and OPKO Biologics, Inc., a subsidiary of OPKO Health, Inc. (OPK ...
Killeen Daily Herald

Local doctor explains what to know about fructose intolerance and malabsorption

Bloating, gas, stomach pain and diarrhea are common digestive complaints, but for some people, the cause is not stress or a ...
MarketWatch

Elgan Pharma and Chiesi Group Announce First Participating Infants Dosed in Phase 3 Study of ELGN-2112 for Treatment of Intestinal Malabsorption in Preterm Infants

Elgan Pharma and Chiesi Farmaceutici S.p.A are collaborating to develop ELGN-2112 NAZARETH, Israel and PARMA, Italy, June 5, 2025 /PRNewswire/ -- Elgan Pharma Ltd. and Chiesi Farmaceutici S.p.A today ...